EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in Xanthan Gum-Based Systems for the Delivery of Therapeutic Agents

Mahima Jadav, Deep Pooja, David J Adams iD, Hitesh Kulhari

Pharmaceutics · 25.01.2023 · 15 (2) · 402

DOI: 10.3390/pharmaceutics15020402 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 25.01.2023. Verfasst von Mahima Jadav und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Nano Sciences, Central University of Gujarat, Gandhinagar 382030, Gujarat, India. Die Arbeit wurde bisher 155-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the last three decades, polymers have contributed significantly to the improvement of drug delivery technologies by enabling the controlled and sustained release of therapeutic agents, versatility in designing different delivery systems, and feasibility of encapsulation of both hydrophobic and hydrophilic molecules. Both natural and synthetic polymers have been explored for the delivery of various therapeutic agents. However, due to the disadvantages of synthetic polymers, such as lack of intrinsic biocompatibility and bioactivity, hydrophobicity, and expensive and complex procedure of synthesis, there is a move toward the use of naturally occurring polymers. The biopolymers are generally derived from either plants or microorganisms and have shown a wide range of applications in drug administration due to their hydrophilic nature, biodegradability, biocompatibility, no or low toxicity, abundance, and readily available, ease of chemical modification, etc. This review describes the applications of a biopolymer, xanthan gum (XG), in the delivery of various therapeutic agents such as drugs, genetic materials, proteins, and peptides. XG is a high molecular weight, microbial heteropolysaccharide and is produced as a fermented product of Gram-negative bacteria, Xanthomonas campestris. Traditionally, it has been used as a thickener in liquid formulations and an emulsion stabiliser. XG has several favourable properties for designing various forms of drug delivery systems. Furthermore, the structure of XG can be easily modified using different temperature and pH conditions. Therefore, XG and its derivatives have been explored for various applications in the food, pharmaceutical, and cosmetic industries.

Schlagwörter

Stichwörter der Autor:innen

biopolymerscontrolled releasedrug deliverynanoparticlesphysiochemical propertiespolysaccharides

Autor:innen und Institutionen

  • School of Nano Sciences, Central University of Gujarat, Gandhinagar 382030, Gujarat, India.
  • School of Pharmacy, National Forensic Science University, Gandhinagar 382007, Gujarat, India.
  • Illawarra Health and Medical Research Institute (IHMRI), University of Wollongong, Wollongong, NSW 2522, Australia.

ORCID-Profile: David J Adams

Zitieren

APA

Jadav, M., Pooja, D., Adams, D. J., & Kulhari, H. (2023). Advances in Xanthan Gum-Based Systems for the Delivery of Therapeutic Agents. Pharmaceutics, 15(2), 402. https://doi.org/10.3390/pharmaceutics15020402

Vancouver

Jadav M, Pooja D, Adams DJ, Kulhari H. Advances in Xanthan Gum-Based Systems for the Delivery of Therapeutic Agents. Pharmaceutics. 2023;15(2):402. doi:10.3390/pharmaceutics15020402

BibTeX
@article{Jadav2023,
  author = {Jadav, Mahima and Pooja, Deep and Adams, David J and Kulhari, Hitesh},
  title = {Advances in Xanthan Gum-Based Systems for the Delivery of Therapeutic Agents},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {2},
  pages = {402},
  doi = {10.3390/pharmaceutics15020402}
}
Kostenlos starten →